FDA Clears New Capabilities for Diabetes App BlueStar
The app-based system can now make insulin dose recommendations based on continuous glucose monitor (CGM) data.
Medscape Medical News
source https://www.medscape.com/viewarticle/995972?src=rss
Medscape Medical News
source https://www.medscape.com/viewarticle/995972?src=rss
Comments
Post a Comment